• LAA Closure for Stroke Prevention: Patient Selection and Practical Considerations

    Sponsored by SCAI, Co-sponsored by HRS and EDUCARE

    Saturday, October 14, 2017 | 12:30 PM - 1:30 PM

    Great Wall International Congress of Cardiology, China National Convention Center
    Beijing
    China

    LAA Closure for Stroke Prevention—Patient Selection and Practical Considerations

    Program Chair:


    Saibal Kar, MD, FSCAI

    Atrial Fibrillation (AFib) is the most common cardiac arrhythmia which affects more than 10 million people in China. Approximately 90% of strokes in AFib are caused by blood clots that form in the left atrial appendage (LAA). Oral anticoagulation (OAC) is the standard treatment to reduce the risk, however, a significant portion of the patient population has contraindications to OAC. For these patients, LAA closure (LAAC) is likely the answer.

    Honorary President:


    Yaling Han, MD, FSCAI 

    Join us for a multi-disciplinary discussion designed to provide cardiologists and other healthcare providers with the latest information on the technologies, indications, and outcomes of LAA to prevent cardioembolic stroke. This evidence- and case-based symposium is designed to provide an overview of all treatment modalities—from current clinical data to how to perform the procedure—and methods to work through any complications to provide better care to patients.

    Facilitators: Yongjian Wu, MD, FSCAI, Hou Dongming, MD, FSCAI, Daxin Zhou, MD

    Agenda:

    • Introduction and Overview—Saibal Kar, MD, FSCAI
    • The Management of AF-Related Stroke: A Cross-Specialty Collaborative Approach—Yongjian Wu, MD, FSCAI
    • AF-Related Stroke Management from a Neurologist Perspective—Haitao Hu, MD
    • LAAC and Stroke Prevention: Why to Close the LAA and How to Do It Safely—Saibal Kar, MD, FSCAI
      A presentation on clinical data, procedure steps, and complication avoidance
    • Which Patients Should Be Considered for LAAC?
      • Case study—Yigang Li, MD
      • Case study—Weijian Huang, MD, FSCAI
    • General Discussion and Closing Comments           

    Acknowledgements: 

    Sponsored by SCAI and co-sponsored by HRS and Boston Scientific’s EDUCARE Global Education Initiative.